慢性阻塞性肺疾病诊断、处理和预防全球策略 (2017GOLD报告)解读

2017-01-11 国际呼吸杂志.2017

自从2001年慢性阻塞性肺疾病全球倡议(GOLD)颁布第1版慢性阻塞性肺疾病诊断、处理和预防全球策略(简称慢阻肺全球策略),至今已整整16年了,16年中慢性阻塞性肺疾病(慢阻肺,COPD)的临床研究取得了相当大的进展。2016年11月16日(世界慢阻肺日),在美国费城举办的GOLDCOPDCare年会上,颁布了“Globalstrategyforthediagnosis,management,an

中文标题:

慢性阻塞性肺疾病诊断、处理和预防全球策略 (2017GOLD报告)解读

发布机构:

发布日期:

2017-01-11

简要介绍:

自从2001年慢性阻塞性肺疾病全球倡议(GOLD)颁布第1版慢性阻塞性肺疾病诊断、处理和预防全球策略(简称慢阻肺全球策略),至今已整整16年了,16年中慢性阻塞性肺疾病(慢阻肺,COPD)的临床研究取得了相当大的进展。2016年11月16日(世界慢阻肺日),在美国费城举办的GOLDCOPDCare年会上,颁布了“Globalstrategyforthediagnosis,management,andpreventionofchronicobstructivepulmonarydisease(2017GOLDReport)”(简称2017GOLD报告)。这是在原有慢阻肺全球策略的基础上,根据慢阻肺研究的最新进展,GOLD发表关于慢阻肺的最新报告。


拓展指南:慢性阻塞性肺疾病相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=慢性阻塞性肺疾病诊断、处理和预防全球策略 (2017GOLD报告)解读)] GetToolGuiderByIdResponse(projectId=1, id=9bfcb1c0013a90d8, title=慢性阻塞性肺疾病诊断、处理和预防全球策略 (2017GOLD报告)解读, enTitle=, guiderFrom=国际呼吸杂志.2017, authorId=null, author=, summary=自从2001年慢性阻塞性肺疾病全球倡议(GOLD)颁布第1版慢性阻塞性肺疾病诊断、处理和预防全球策略(简称慢阻肺全球策略),至今已整整16年了,16年中慢性阻塞性肺疾病(慢阻肺,COPD)的临床研究取得了相当大的进展。2016年11月16日(世界慢阻肺日),在美国费城举办的GOLDCOPDCare年会上,颁布了“Globalstrategyforthediagnosis,management,an, cover=, journalId=null, articlesId=null, associationId=null, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Wed Jan 11 18:24:49 CST 2017, originalUrl=, linkOutUrl=, content=自从2001年慢性阻塞性肺疾病全球倡议(GOLD)颁布第1版慢性阻塞性肺疾病诊断、处理和预防全球策略(简称慢阻肺全球策略),至今已整整16年了,16年中慢性阻塞性肺疾病(慢阻肺,COPD)的临床研究取得了相当大的进展。2016年11月16日(世界慢阻肺日),在美国费城举办的GOLDCOPDCare年会上,颁布了“Globalstrategyforthediagnosis,management,andpreventionofchronicobstructivepulmonarydisease(2017GOLDReport)”(简称2017GOLD报告)。这是在原有慢阻肺全球策略的基础上,根据慢阻肺研究的最新进展,GOLD发表关于慢阻肺的最新报告。<br> <div><br> </div> 拓展指南:<strong>与<font color="red">慢性阻塞性肺疾病</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=9bfcb1c0013a90d8" title="慢性阻塞性肺疾病诊断、处理和预防全球 策略 (2017GOLD报告)解读" target="_blank">慢性阻塞性肺疾病诊断、处理和预防全球 策略 (2017GOLD报告)解读</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=e24731c0013315f2" title="2017 GOLD慢性阻塞性肺疾病全球倡议:COPD诊断、治疗与预防全球策略" target="_blank">2017 GOLD慢性阻塞性肺疾病全球倡议:COPD诊断、治疗与预防全球策略</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=05fcc1c00123866d" title="2013 慢性阻塞性肺疾病诊治指南(2013年修订版)" target="_blank">2013 慢性阻塞性肺疾病诊治指南(2013年修订版)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=2d2ba1c001183615" title="ICSI:2016慢性阻塞性肺疾病(COPD)的诊断和处理" target="_blank">ICSI:2016慢性阻塞性肺疾病(COPD)的诊断和处理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=768961c001168321" title="2016版GOLD慢性阻塞性肺疾病全球倡议主要更新内容" target="_blank">2016版GOLD慢性阻塞性肺疾病全球倡议主要更新内容</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E6%85%A2%E6%80%A7%E9%98%BB%E5%A1%9E%E6%80%A7%E8%82%BA%E7%96%BE%E7%97%85" target="_blank">有关慢性阻塞性肺疾病更多指南</a></ul>, tagList=[TagDto(tagId=2115, tagName=慢性阻塞性肺疾病), TagDto(tagId=757, tagName=诊断), TagDto(tagId=101008, tagName=处理和预防全球策略)], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4446, appHits=607, showAppHits=0, pcHits=2738, showPcHits=1445, likes=101, shares=36, comments=6, approvalStatus=1, publishedTime=Wed Jan 11 18:24:49 CST 2017, publishedTimeString=2017-01-11, pcVisible=1, appVisible=1, editorId=5295957, editor=lili, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=lili, createdTime=Wed Jan 11 18:24:49 CST 2017, updatedBy=null, updatedName=null, updatedTime=Thu Jan 04 17:11:55 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=慢性阻塞性肺疾病诊断、处理和预防全球策略 (2017GOLD报告)解读)])
慢性阻塞性肺疾病诊断、处理和预防全球策略 (2017GOLD报告)解读
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=171360, encodeId=5e751e1360c3, content=谢谢分享,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Thu Jan 19 11:59:29 CST 2017, time=2017-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171213, encodeId=ac8f1e12130a, content=哈哈哈, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f2c1569961, createdName=229514421, createdTime=Wed Jan 18 23:04:29 CST 2017, time=2017-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169776, encodeId=70ea169e7676, content=学习啦,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/31/60fc0213ae09a3dbbba19993663ef4db.jpg, createdBy=33c31971480, createdName=1e160a78m83(暂无匿称), createdTime=Thu Jan 12 08:11:28 CST 2017, time=2017-01-12, status=1, ipAttribution=)]
    2017-01-19 明月清辉

    谢谢分享,学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=171360, encodeId=5e751e1360c3, content=谢谢分享,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Thu Jan 19 11:59:29 CST 2017, time=2017-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171213, encodeId=ac8f1e12130a, content=哈哈哈, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f2c1569961, createdName=229514421, createdTime=Wed Jan 18 23:04:29 CST 2017, time=2017-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169776, encodeId=70ea169e7676, content=学习啦,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/31/60fc0213ae09a3dbbba19993663ef4db.jpg, createdBy=33c31971480, createdName=1e160a78m83(暂无匿称), createdTime=Thu Jan 12 08:11:28 CST 2017, time=2017-01-12, status=1, ipAttribution=)]
    2017-01-18 229514421

    哈哈哈

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=171360, encodeId=5e751e1360c3, content=谢谢分享,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Thu Jan 19 11:59:29 CST 2017, time=2017-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171213, encodeId=ac8f1e12130a, content=哈哈哈, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f2c1569961, createdName=229514421, createdTime=Wed Jan 18 23:04:29 CST 2017, time=2017-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169776, encodeId=70ea169e7676, content=学习啦,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/31/60fc0213ae09a3dbbba19993663ef4db.jpg, createdBy=33c31971480, createdName=1e160a78m83(暂无匿称), createdTime=Thu Jan 12 08:11:28 CST 2017, time=2017-01-12, status=1, ipAttribution=)]
    2017-01-12 1e160a78m83(暂无匿称)

    学习啦,谢谢分享

    0